Phase I and pharmacokinetic study of elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies.

Authors	F J Giles, N Vey, D Rizzieri, F Ravandi, T Prebet, G Borthakur, T F Jacobsen, S Hagen, B Nilsson, S O'Brien
Journal	Leukemia (Leukemia) Vol. 26 Issue 7 Pg. 1686-9 (Jul 2012) ISSN: 1476-5551 [Electronic] England
PMID	22222600 (Publication Type: Letter)
Chemical References	Cytarabine 5'-oleoyl cytarabine
Topics	Adult Cytarabine (analogs & derivatives, blood, pharmacokinetics, therapeutic use) Hematologic Neoplasms (drug therapy) Humans Middle Aged Prognosis Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!